Open AccessHyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy
Author(s) -
Nada Dimković,
Tanja Djordjević,
Jovan Popović,
Siniša Dimković,
Biserka Tirmenštajn-Janković,
M Zivanović,
Jasminka Bobanović-Hasković
Publication year - 2006
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh0602044d
Subject(s) - medicine , fosinopril , enalapril , hyperkalemia , hemodialysis , blood pressure , dialysis , cardiology , urology , angiotensin converting enzyme , doxazosin , left ventricular hypertrophy , bisoprolol
Hypertension is evident in 80%-85% of patients with chronic renal failure and antihypertensive therapy is needed in 25%-30% of patients. Apart from antihypertensive effect, ACEi's decrease the left ventricular hypertrophy and mortality in dialysis patients. Even so, their use is limited due to hyperkalemia.